Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid-Withdrawal 'Aids' Warrant Immediate FDA, FTC Action – CSPI

Dec 15 2017

• By Eileen Francis

Related Content

Sturman Leads Nature's Bounty For New Owner: Health And Wellness Industry News

Sep 29 2017

Kratom Supplement Marketers Dispute FDA Warning, Ask For Review

Nov 16 2017

Opiate Addiction Remedy Claims Could Face FTC Substantiation Test

Nov 06 2017

FDA Turns Kratom's Future In US Dietary Supplement Market Into History

Nov 15 2017

Additional Topics

FDA Regulation Advertising, Marketing & Sales Cosmetics Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window